Furthermore, obeticholic acid, a semi-synthetic agonist of farnesoid X receptor (FXR), has been shown to affect bile acid abnormalities, improve cholestasis, and promote liver regeneration [150,160]. Here, NR1H4 is linked to cholestasis.